v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 28, 2026
Feb. 28, 2025
Cash Flows used in Operating Activities    
Net loss $ (12,299) $ (15,057)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization (Notes 6 and 7) 384 524
Stock-based compensation (Note 19) 1,453 1,352
Impairment of machinery & equipment (Note 6) 0 8,460
Write-down of inventory (Note 4) 130 0
Accrued interest and other financing costs (Note 21) 1,520 359
Loss on equity method investments (Note 11) 763 687
Changes in operating assets and liabilities:    
Accounts receivable and other (Note 3) (78) (322)
Inventories (Note 4) (44) 14
Prepaid expenses (Note 5) (328) 410
Accounts payable and accrued liabilities (Note 9) (1,743) 1,350
Unearned revenue (Note 16) 132 102
Net cash used in operating activities (10,110) (2,121)
Cash Flows used in Investing Activities    
Distribution from equity investment (Note 11) 0 368
Contributions to equity method investments (Note 11) (960) (1,954)
Additions to intangible assets (Note 7) (211) (450)
Net cash used in investing activities (1,171) (2,036)
Cash Flows used in Financing Activities    
Proceeds from issuance of series B Convertible Preferred stock (Note 12) 0 10,395
Proceeds from exercise of stock options (Note 15) 64 0
Proceeds from ATM equity offering, net of issuance costs (Note 15) 889 0
Repayment of long-term debt (Note 13) (275) (77)
Net cash provided by financing activities 678 10,318
Net change in cash and cash equivalents (10,617) 6,015
Cash and cash equivalents, beginning of year 12,973 6,958
Cash and cash equivalents, end of year 2,356 12,973
Effect of exchange rate changes (14) (146)
Supplemental Disclosure of Cash Flow Information:    
Income tax paid 0 0
Interest paid 183 257
Interest received $ 236 $ 307